Physician profile
Robert Debiec
NPI 1487651881
$833.02
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $169 · 2021: $147 · 2022: $253.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $216.44 | 2019-2022 | |
| Organogenesis INC. | $194.55 | 2020-2022 | |
| Misonix INC | $133.28 | 2020-2021 | |
| Integra Lifesciences Corporation | $107.20 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $85.90 | 2019 | |
| 3m Company | $55.25 | 2019 | |
| Merck Sharp & Dohme LLC | $14.56 | 2019 | |
| Arthrosurface Incorporated | $13.20 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.64 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Debiec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.